Aquestive Therapeutics
AQST
AQST
97 hedge funds and large institutions have $177M invested in Aquestive Therapeutics in 2024 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
64% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 14
10.46% more ownership
Funds ownership: 35.66% → 46.12% (+10%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
97
Holding in Top 10
3
Calls
$4.24M
Puts
$1.97M
Top Buyers
| 1 | +$23.7M | |
| 2 | +$9.46M | |
| 3 | +$6.58M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.77M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$4.26M |
Top Sellers
| 1 | -$7.93M | |
| 2 | -$994K | |
| 3 | -$584K | |
| 4 |
Two Sigma Investments
New York
|
-$479K |
| 5 |
Corient Private Wealth
Miami,
Florida
|
-$408K |